Publications
Detailed Information
Impairment of Nuclear Factor-κB Activation Increased Glutamate Excitotoxicity in a Motoneuron-Neuroblastoma Hybrid Cell Line Expressing Mutant (G93A) Cu/Zn-Superoxide Dismutase
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Pyo, Jung-Soo | - |
dc.contributor.author | Ko, Young San | - |
dc.contributor.author | Kim, Woo Ho | - |
dc.contributor.author | Kim, Manho | - |
dc.contributor.author | Nam, Seon Young | - |
dc.contributor.author | Cho, Sung Jin | - |
dc.contributor.author | Lee, Byung Lan | - |
dc.contributor.author | Baik, Tai-Kyoung | - |
dc.contributor.author | Chung, Hee-Yong | - |
dc.contributor.author | Lee, Kwang-Woo | - |
dc.date.accessioned | 2012-07-10T04:03:22Z | - |
dc.date.available | 2012-07-10T04:03:22Z | - |
dc.date.issued | 2010-08-15 | - |
dc.identifier.citation | JOURNAL OF NEUROSCIENCE RESEARCH; Vol.88(11); 2494-2503 | ko_KR |
dc.identifier.issn | 0360-4012 | - |
dc.identifier.uri | https://hdl.handle.net/10371/78692 | - |
dc.description.abstract | Mutations in the superoxide dismutase 1 (SOD1) gene are linked to glutamate excitotoxicity in familial amyotrophic lateral sclerosis (fALS), but the underlying mechanism remains unclear. We investigated whether nuclear factor-kappa B (NE-kappa B) activation is involved in glutamate excitotoxicity by using motor neuron neuroblastoma hybrid cells that expressed a mutant (G93A) SOD1 (mtSOD1) or wild-type SOD1 (wtSOD1). MtSOD1 cells were more vulnerable to glutamate excitotoxicity than wtSOD1 cells and showed higher NE-kappa B activity, higher nuclear cRel expression, and lower nuclear RelA expression under basal conditions. Glutamate treatment increased NF-kappa B activation along with nuclear expressions of RelA and cRel in wtSOD1 cells but induced only weak nuclear RelA expression in mtSOD1 cells. Suppression of NF-kappa B activation using transfection of the superrepressive mutant form of l kappa B alpha (Ml kappa B alpha) inhibited nuclear RelA expression in both types of SOD1 cells, which increased glutamate excitotoxicity in wtSOD1 cells but not in mtS0D1 cells. Furthermore, immunohistochemistry confirmed stronger RelA immunoreactivity in the nuclei of motor neurons of spinal cord in wild-type SOD1 transgenic mice than in those in SOD1 G93A transgenic mice. In addition, we found that glutamate treatment decreased XIAP expression and increased caspase-3 activity in mtSOD1 cells and mIKBet-overexpressing wtSOD1 cells. Our results suggest that glutamate excitotoxicity in motor neurons of SOD1-linked fALS is attributable, at least in part, to the impairment of l kappa B alpha-dependent RelA activation and subsequent apoptosis mediated by XIAP inhibition and caspase-3 activation. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WILEY-LISS | ko_KR |
dc.subject | familial amyotrophic lateral sclerosis | ko_KR |
dc.subject | nuclear factor-κB | ko_KR |
dc.subject | glutamate excitotoxicity | ko_KR |
dc.subject | mutant Cu/Zn superoxide dismutase | ko_KR |
dc.subject | motor neurons | ko_KR |
dc.title | Impairment of Nuclear Factor-κB Activation Increased Glutamate Excitotoxicity in a Motoneuron-Neuroblastoma Hybrid Cell Line Expressing Mutant (G93A) Cu/Zn-Superoxide Dismutase | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 표정수 | - |
dc.contributor.AlternativeAuthor | 고영산 | - |
dc.contributor.AlternativeAuthor | 김우호 | - |
dc.contributor.AlternativeAuthor | 김만호 | - |
dc.contributor.AlternativeAuthor | 이광우 | - |
dc.contributor.AlternativeAuthor | 남선영 | - |
dc.contributor.AlternativeAuthor | 정희용 | - |
dc.contributor.AlternativeAuthor | 조성진 | - |
dc.contributor.AlternativeAuthor | 백태경 | - |
dc.contributor.AlternativeAuthor | 이병란 | - |
dc.identifier.doi | 10.1002/jnr.22397 | - |
dc.citation.journaltitle | JOURNAL OF NEUROSCIENCE RESEARCH | - |
dc.description.citedreference | Fan W, 2009, INVEST OPHTH VIS SCI, V50, P917, DOI 10.1167/iovs.08-2555 | - |
dc.description.citedreference | Lee CH, 2007, BIOFACTORS, V29, P19 | - |
dc.description.citedreference | Memet S, 2006, BIOCHEM PHARMACOL, V72, P1180, DOI 10.1016/j.bcp.2006.09.003 | - |
dc.description.citedreference | Pizzi M, 2006, EUR J PHARMACOL, V545, P22, DOI 10.1016/j.ejphar.2006.06.027 | - |
dc.description.citedreference | Harris J, 2006, J IMMUNOL, V177, P2527 | - |
dc.description.citedreference | Tergaonkar V, 2006, INT J BIOCHEM CELL B, V38, P1647, DOI 10.1016/j.biocel.2006.03.023 | - |
dc.description.citedreference | Ishige K, 2005, NEUROCHEM INT, V47, P545, DOI 10.1016/j.neuint.2005.07.010 | - |
dc.description.citedreference | Pizzi M, 2005, CELL DEATH DIFFER, V12, P761, DOI 10.1038/sj.cdd.4401598 | - |
dc.description.citedreference | Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205 | - |
dc.description.citedreference | Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379 | - |
dc.description.citedreference | Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074 | - |
dc.description.citedreference | Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tiba.2004.11.009 | - |
dc.description.citedreference | Kunst CB, 2004, AM J HUM GENET, V75, P933 | - |
dc.description.citedreference | Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008 | - |
dc.description.citedreference | Nam SY, 2003, CANCER SCI, V94, P1066 | - |
dc.description.citedreference | Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191 | - |
dc.description.citedreference | Chen XF, 2003, CANCER RES, V63, P1059 | - |
dc.description.citedreference | Dunlop J, 2003, J NEUROSCI, V23, P1688 | - |
dc.description.citedreference | Casciati A, 2002, J NEUROCHEM, V83, P1019 | - |
dc.description.citedreference | Lee KW, 2002, INT J DEV NEUROSCI, V20, P521 | - |
dc.description.citedreference | Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200 | - |
dc.description.citedreference | Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830 | - |
dc.description.citedreference | Flanagan SW, 2002, J NEUROCHEM, V81, P170 | - |
dc.description.citedreference | Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604 | - |
dc.description.citedreference | Gelinas DF, 2000, AMYOTROPH LATERAL SC, V1, P3 | - |
dc.description.citedreference | Karin M, 2000, ANNU REV IMMUNOL, V18, P621 | - |
dc.description.citedreference | Gilmore TD, 1999, ONCOGENE, V18, P6842 | - |
dc.description.citedreference | Tamatani M, 1999, J BIOL CHEM, V274, P8531 | - |
dc.description.citedreference | Wang XT, 1997, ONCOGENE, V15, P2991 | - |
dc.description.citedreference | Mattson MP, 1997, J NEUROSCI RES, V49, P681 | - |
dc.description.citedreference | Hunot S, 1997, P NATL ACAD SCI USA, V94, P7531 | - |
dc.description.citedreference | Gurney ME, 1997, J NEUROL, V244, pS15 | - |
dc.description.citedreference | Gurney ME, 1996, ANN NEUROL, V39, P147 | - |
dc.description.citedreference | KIM WH, 1994, CANCER RES, V54, P5005 | - |
dc.description.citedreference | GURNEY ME, 1994, SCIENCE, V264, P1772 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.